N-substituted glycine derivatives: hydroxylase inhibitors
USRE44613E1 · kind E1 · reissue
4Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2011 |
| Grant date | Nov 26, 2013 |
| Priority date | — |
| Expiry date | Oct 26, 2031 |
Classification
- Technology area (CPC —)General
Abstract
The invention described herein relates to certain pyridazinedione N-substituted glycine derivatives of formula (I)which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.